Paperback
AI revolutionizes Alzheimer’s diagnosis, prediction, and drug discovery.

AI-Neuro

Artificial Intelligence Applications to Neurology and Neurodegenerative Diseases

$164.40

  • Paperback

    450 pages

  • Release Date

    26 September 2026

Check Delivery Options

Summary

Artificial intelligence (AI) refers to a system that can simulate and execute the processes of human thinking and learning and make informed decisions. It can have several applications in neurology and neurodegenerative diseases which present fundamental challenges not merely in their biology but also in their modeling.

In the case of Alzheimer’s - an incredibly heterogeneous disease that is difficult to predict, diagnose, and treat - AI can improve how the disease is detected, especi…

Book Details

ISBN-13:9781834546087
ISBN-10:1834546087
Author:Alain L. Fymat
Publisher:Tellwell Talent
Imprint:Tellwell Talent
Format:Paperback
Number of Pages:450
Release Date:26 September 2026
Weight:1.44kg
Dimensions:30mm x 216mm x 279mm
A-Format
B-Format
C-Format
AI-Neuro by Alain L. Fymat - ISBN: 9781834546087
216 × 279 mm
A4
mm / in
About The Author

Alain L. Fymat

Dr. Alain L. Fymat

Dr. Alain L. Fymat is a medical-physical scientist and educator. He currently serves as President/CEO and Institute Professor at the International Institute of Medicine & Science. Previously, he held the positions of Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine.

Dr. Fymat has also been a Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at various U.S. and European universities. Earlier in his career, he was the Deputy Director (Western Region) for the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he held the roles of Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center, and served as Acting Chair of Radiology for a period. Before that, he was the Director of the Division of Biomedical and Biobehavioral Research at UCLA/Drew University of Medicine and Science.

Dr. Fymat has also served as Scientific Advisor to the U.S. National Academy of Sciences, National Research Council, for its postdoctoral programs at the California Institute of Technology. He was also a Member of the Advisory Group for Research & Development for the North Atlantic Treaty Organization (NATO). Currently, he is a Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California.

He is a frequent keynote speaker and a member of scientific organizing committees for numerous international scientific and medical conferences. Dr. Fymat has lectured widely across the U.S.A., Canada, Europe, Asia, and Africa.

Dr. Fymat’s current research interests are concentrated on neurodegenerative diseases, including Alzheimer’s, Parkinson’s, dementias, epilepsy, multiple sclerosis, multiple system atrophy, Huntington’s disease, and others.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.